Benefit of Combined Resynchronization and Defibrillator Therapy in Heart Failure Patients With and Without Ventricular Arrhythmias
Claudia Ypenburg, MD,
Lieselot van Erven, MD, PhD,
Gabe B. Bleeker, MD,
Jeroen J. Bax, MD, PhD,
Marianne Bootsma, MD, PhD,
Maurits C. Wijffels, MD, PhD,
Ernst E. van der Wall, MD, PhD and
Martin J. Schalij, MD, PhD*
Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands
View larger version (15K):
[in a new window]
|
Figure 1 Appropriate implantable cardioverter-defibrillator (ICD) therapy rate in primary and secondary prevention patients.
|
|
View larger version (14K):
[in a new window]
|
Figure 2 Survival curve for primary and secondary prevention patients.
|
|
View larger version (13K):
[in a new window]
|
Figure 3 Cardiac event curve for primary and secondary prevention patients.
|
|
|
